Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 192

1.

Evaluation of benznidazole treatment combined with nifurtimox, posaconazole or AmBisome® in mice infected with Trypanosoma cruzi strains.

Cencig S, Coltel N, Truyens C, Carlier Y.

Int J Antimicrob Agents. 2012 Dec;40(6):527-32. doi: 10.1016/j.ijantimicag.2012.08.002. Epub 2012 Oct 12.

PMID:
23063742
2.

New, combined, and reduced dosing treatment protocols cure Trypanosoma cruzi infection in mice.

Bustamante JM, Craft JM, Crowe BD, Ketchie SA, Tarleton RL.

J Infect Dis. 2014 Jan 1;209(1):150-62. doi: 10.1093/infdis/jit420. Epub 2013 Aug 14.

3.

Parasitic loads in tissues of mice infected with Trypanosoma cruzi and treated with AmBisome.

Cencig S, Coltel N, Truyens C, Carlier Y.

PLoS Negl Trop Dis. 2011 Jun;5(6):e1216. doi: 10.1371/journal.pntd.0001216. Epub 2011 Jun 28.

4.
5.

Benznidazole and posaconazole in experimental Chagas disease: positive interaction in concomitant and sequential treatments.

Diniz Lde F, Urbina JA, de Andrade IM, Mazzeti AL, Martins TA, Caldas IS, Talvani A, Ribeiro I, Bahia MT.

PLoS Negl Trop Dis. 2013 Aug 15;7(8):e2367. doi: 10.1371/journal.pntd.0002367. eCollection 2013.

6.

Randomized trial of posaconazole and benznidazole for chronic Chagas' disease.

Molina I, Gómez i Prat J, Salvador F, Treviño B, Sulleiro E, Serre N, Pou D, Roure S, Cabezos J, Valerio L, Blanco-Grau A, Sánchez-Montalvá A, Vidal X, Pahissa A.

N Engl J Med. 2014 May 15;370(20):1899-908. doi: 10.1056/NEJMoa1313122.

7.

Benznidazole/Itraconazole Combination Treatment Enhances Anti-Trypanosoma cruzi Activity in Experimental Chagas Disease.

Assíria Fontes Martins T, de Figueiredo Diniz L, Mazzeti AL, da Silva do Nascimento ÁF, Caldas S, Caldas IS, de Andrade IM, Ribeiro I, Bahia MT.

PLoS One. 2015 Jun 15;10(6):e0128707. doi: 10.1371/journal.pone.0128707. eCollection 2015.

8.

Absence of CD4+ T lymphocytes, CD8+ T lymphocytes, or B lymphocytes has different effects on the efficacy of posaconazole and benznidazole in treatment of experimental acute Trypanosoma cruzi infection.

Ferraz ML, Gazzinelli RT, Alves RO, Urbina JA, Romanha AJ.

Antimicrob Agents Chemother. 2009 Jan;53(1):174-9. doi: 10.1128/AAC.00779-08. Epub 2008 Nov 10.

10.

Treatment with benznidazole and its immunomodulating effects on Trypanosoma cruzi-infected rats.

Piaggio E, Roggero E, Pitashny M, Wietzerbin J, Bottasso OA, Revelli SS.

Parasitol Res. 2001 Jul;87(7):539-47.

PMID:
11484850
11.

Fexinidazole: a potential new drug candidate for Chagas disease.

Bahia MT, de Andrade IM, Martins TA, do Nascimento ÁF, Diniz Lde F, Caldas IS, Talvani A, Trunz BB, Torreele E, Ribeiro I.

PLoS Negl Trop Dis. 2012;6(11):e1870. doi: 10.1371/journal.pntd.0001870. Epub 2012 Nov 1.

12.

Response to chemotherapy with benznidazole of clones isolated from the 21SF strain of Trypanosoma cruzi (biodeme Type II, Trypanosoma cruzi II).

Campos RF, Guerreiro ML, Sobral Kde S, Lima Rde C, Andrade SG.

Rev Soc Bras Med Trop. 2005 Mar-Apr;38(2):142-6. Epub 2005 Mar 30.

13.

Usefulness of the polymerase chain reaction for monitoring cure of mice infected with different Trypanosoma cruzi clonal genotypes following treatment with benznidazole.

Miyamoto CT, Gomes ML, Marangon AV, de Araújo SM, Bahia MT, Martins-Filho OA, de Lana M, de Ornelas Toledo MJ.

Exp Parasitol. 2008 Sep;120(1):45-9. doi: 10.1016/j.exppara.2008.04.018. Epub 2008 May 1.

PMID:
18533149
14.

The Anti-Trypanosoma cruzi activity of posaconazole in a murine model of acute Chagas' disease is less dependent on gamma interferon than that of benznidazole.

Ferraz ML, Gazzinelli RT, Alves RO, Urbina JA, Romanha AJ.

Antimicrob Agents Chemother. 2007 Apr;51(4):1359-64. Epub 2007 Jan 12.

15.

In vivo selection of a population of Trypanosoma cruzi and clones resistant to benznidazole.

Murta SM, Romanha AJ.

Parasitology. 1998 Feb;116 ( Pt 2):165-71.

PMID:
9509026
16.

Antitrypanosomal Treatment with Benznidazole Is Superior to Posaconazole Regimens in Mouse Models of Chagas Disease.

Khare S, Liu X, Stinson M, Rivera I, Groessl T, Tuntland T, Yeh V, Wen B, Molteni V, Glynne R, Supek F.

Antimicrob Agents Chemother. 2015 Oct;59(10):6385-94. doi: 10.1128/AAC.00689-15. Epub 2015 Aug 3.

17.

Decreased intensity of inflammation in benznidazole-treated mice inoculated with Trypanosoma cruzi I stocks from Mexico and persistence of circulating parasites.

Cruz-Zetina G, del Rio-Rodriguez R, Ramos-Ligonio A, López R, Monteon V.

Am J Trop Med Hyg. 2012 Oct;87(4):671-4. doi: 10.4269/ajtmh.2012.11-0519. Epub 2012 Aug 13.

18.

Benznidazole alters the pattern of Cyclophosphamide-induced reactivation in experimental Trypanosoma cruzi-dependent lineage infection.

Santos DM, Martins TA, Caldas IS, Diniz LF, Machado-Coelho GL, Carneiro CM, Oliveira Rde P, Talvani A, Lana M, Bahia MT.

Acta Trop. 2010 Feb;113(2):134-8. doi: 10.1016/j.actatropica.2009.10.007. Epub 2009 Oct 23.

PMID:
19854145
19.

Hepatotoxicity in mice of a novel anti-parasite drug candidate hydroxymethylnitrofurazone: a comparison with Benznidazole.

Davies C, Dey N, Negrette OS, Parada LA, Basombrio MA, Garg NJ.

PLoS Negl Trop Dis. 2014 Oct 16;8(10):e3231. doi: 10.1371/journal.pntd.0003231. eCollection 2014 Oct.

20.

Evaluation of nifurtimox treatment of chronic Chagas disease by means of several parasitological methods.

Muñoz C, Zulantay I, Apt W, Ortiz S, Schijman AG, Bisio M, Ferrada V, Herrera C, Martínez G, Solari A.

Antimicrob Agents Chemother. 2013 Sep;57(9):4518-23. doi: 10.1128/AAC.00227-13. Epub 2013 Jul 8.

Items per page

Supplemental Content

Write to the Help Desk